Meridian Investment Counsel’s abrdn Life Sciences Investors HQL Stock Holding History

Meridian Investment Counsel’s Portfolio HQL Stock Details HQL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-10,163	Closed	-$199K	–	188
2017 Q4	$199K	Sell	10,163 -32	-0.3%	-$641	0.11%	174
2017 Q3	$219K	Hold	10,195	–	–	0.13%	162
2017 Q2	$213K	Hold	10,195	–	–	0.13%	162
2017 Q1	$198K	Hold	10,195	–	–	0.12%	166
2016 Q4	$173K	Hold	10,195	–	–	0.12%	158
2016 Q3	$191K	Hold	10,195	–	–	0.13%	158
2016 Q2	$175K	Hold	10,195	–	–	0.12%	155
2016 Q1	$183K	Sell	10,195 -2,000	-16%	-$36.3K	0.13%	159
2015 Q4	$288K	Hold	12,195	–	–	0.21%	118
2015 Q3	$275K	Hold	12,195	–	–	0.23%	112
2015 Q2	$344K	Sell	12,195 -800	-6%	-$22.2K	0.25%	106
2015 Q1	$358K	Hold	12,995	–	–	0.25%	106
2014 Q4	$323K	Hold	12,995	–	–	0.23%	109
2014 Q3	$287K	Sell	12,995 -1,418	-10%	-$30.8K	0.21%	120
2014 Q2	$299K	Buy	14,413 +3,253	+29%	+$68.3K	0.23%	115
2014 Q1	$243K	Hold	11,160	–	–	0.21%	125
2013 Q4	$228K	Buy	+11,160	New	+$216K	0.19%	125

Other funds holding HQL

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

NIM

Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

FHA

Flagship Harbor Advisors Boston, Massachusetts $2.61B AUM 23.21% 1-Year Est. Return

CAN

Claraphi Advisory Network Aliso Viejo, United States $251M AUM 9.29% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

Meridian Investment Counsel's HQL Position: Q1 2018 in Review

Meridian Investment Counsel sold out of abrdn Life Sciences Investors (HQL) in Q1 2018, closing a stake of 10,163 shares — an estimated $199K sold.

Meridian Investment Counsel first reported a position in HQL in Q4 2013 and held it in 17 quarters. The position peaked at $358K in Q1 2015. 56 funds tracked by Wall St. Rank hold HQL as of Q1 2018.

Meridian Investment Counsel reported no remaining abrdn Life Sciences Investors position as of Q1 2018 after selling out during the quarter.
Meridian Investment Counsel sold 10,163 abrdn Life Sciences Investors shares in Q1 2018, an estimated $199K.
Meridian Investment Counsel first reported a position in abrdn Life Sciences Investors in Q4 2013 and held it in 17 quarters.
Meridian Investment Counsel's abrdn Life Sciences Investors position peaked at $358K in Q1 2015.
56 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q1 2018.

Based on Meridian Investment Counsel's 13F filing for Q1 2018, filed 14 May 2018.